Back to Search Start Over

The Importance of Patient-Reported Outcome Measures (PROMs) in Oncological Vulvoperineal Defect Reconstruction: A Systematic Review.

Authors :
Speck, Nicole E.
Stoffel, Julia
Wendelspiess, Séverin
Appenzeller-Herzog, Christian
Schaefer, Kristin M.
Kouba, Loraine P.
Rüter, Florian
Montavon, Céline
Heinzelmann-Schwarz, Viola
Haug, Martin D.
Schaefer, Dirk J.
Ismail, Tarek
Kappos, Elisabeth A.
Source :
Current Oncology; Oct2024, Vol. 31 Issue 10, p6300-6313, 14p
Publication Year :
2024

Abstract

Background: Patient-reported outcome measures (PROMs) have gained increased importance in assessing outcomes after reconstructive surgery. This also applies to the reconstruction of vulvoperineal defects after resection of gynecological or colorectal cancers in women. The objective of this study is to analyze the current state of PROM tool use within this patient population. Methods: By systematic literature searches in Embase, Medline, and Web of Science, English-language studies published after 1980, including randomized controlled trials, cohort studies, and case series reporting on vulvoperineal defect reconstruction, which were included if they also analyzed quality of life (QoL) and/or PROMs. The PROM tools used by each study were extracted, analyzed, and compared. Results: The primary search yielded 2576 abstracts, of which 395 articles were retrieved in full text. Of these, 50 reported on vulvoperineal defect reconstruction, among which 27 studies analyzing QoL were found. Of those, 17 met the inclusion criteria for this systematic review. After full-text screening, 14 different PROM tools and 5 individual, non-standardized questionnaires were identified. Only 22% of studies used a validated PROM tool. Conclusion: Far too few studies currently use PROM tools to assess outcomes in oncological vulvoperineal defect reconstruction. Less than half of the used PROMs are validated. No PROM was designed to specifically measure QoL in this patient population. The standardized implementation of a validated PROM tool in the clinical treatment of this patient population is an essential step to improve outcomes, enable the comparison of research, and support evidence-based treatment approaches. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
11980052
Volume :
31
Issue :
10
Database :
Complementary Index
Journal :
Current Oncology
Publication Type :
Academic Journal
Accession number :
180556931
Full Text :
https://doi.org/10.3390/curroncol31100470